Search for members, bills, votes, committees, hearings, and nominations
The Diabetes Prevention Access and Care Act (H.R. 5225) is designed to address the disproportionate impact of diabetes on minority communities through expanded research, education, and prevention programs. The bill directs federal health agencies to develop a coordinated national plan to reduce health disparities and increase the participation of minority populations in clinical trials.
For citizens, this legislation would mean increased public awareness campaigns and improved access to diabetes prevention services within communities of color. It also aims to strengthen the healthcare workforce by funding mentorship programs for minority researchers and addressing the national shortage of specialized doctors, such as pediatric endocrinologists. While the bill was introduced and referred to a subcommittee, it did not advance further in the legislative process during that session of Congress.
AI-generated summary
No events recorded for this stage yet.
No events recorded for this stage yet.
No CBO cost estimate has been published for this bill.